Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $68.1 million.

  • Nuvation Bio's Total Current Liabilities rose 1540.78% to $68.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.1 million, marking a year-over-year increase of 1540.78%. This contributed to the annual value of $58.2 million for FY2024, which is 31680.26% up from last year.
  • Latest data reveals that Nuvation Bio reported Total Current Liabilities of $68.1 million as of Q3 2025, which was up 1540.78% from $66.4 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Total Current Liabilities peaked at $68.1 million during Q3 2025, and registered a low of $12.6 million during Q1 2023.
  • For the 3-year period, Nuvation Bio's Total Current Liabilities averaged around $38.9 million, with its median value being $51.1 million (2024).
  • As far as peak fluctuations go, Nuvation Bio's Total Current Liabilities surged by 31680.26% in 2024, and later surged by 1540.78% in 2025.
  • Over the past 3 years, Nuvation Bio's Total Current Liabilities (Quarter) stood at $14.0 million in 2023, then soared by 316.8% to $58.2 million in 2024, then rose by 16.98% to $68.1 million in 2025.
  • Its last three reported values are $68.1 million in Q3 2025, $66.4 million for Q2 2025, and $52.8 million during Q1 2025.